SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-006363
Filing Date
2013-11-14
Accepted
2013-11-14 15:47:48
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnib_10q.htm 10-Q 699888
2 CERTIFICATION tnib_ex311.htm EX-31.1 14911
3 CERTIFICATION tnib_ex312.htm EX-31.2 14951
4 CERTIFICATION tnib_ex321.htm EX-32.1 7821
5 CERTIFICATION tnib_ex322.htm EX-32.2 7929
  Complete submission text file 0001354488-13-006363.txt   2600704

Data Files

Seq Description Document Type Size
6 tnib-20130930.xml EX-101.INS 274663
7 tnib-20130930.xsd EX-101.SCH 25399
8 tnib-20130930_cal.xml EX-101.CAL 31567
9 tnib-20130930_def.xml EX-101.DEF 36002
10 tnib-20130930_lab.xml EX-101.LAB 166221
11 tnib-20130930_pre.xml EX-101.PRE 102861
Mailing Address 477 SOUTH ROSEMARY AVENUE, SUITE 315 WEST PALM BEACH FL 33401
Business Address 477 SOUTH ROSEMARY AVENUE, SUITE 315 WEST PALM BEACH FL 33401 407-680-3097
TNI BIOTECH, INC. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 131219735
SIC: 2834 Pharmaceutical Preparations